P53 Facilitates BH3-only BID nuclear export to induce apoptosis in the irrepairable DNA damage response

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 850-852

  Song, Gang ^a   Wang, Weiwei ^a   Hu, Tianhui ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BID; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL NUCLEUS; DNA DAMAGE; HUMAN; MITOCHONDRION; MOLECULAR INTERACTION; NUCLEAR EXPORT SIGNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; DNA DAMAGE; NUCLEAR EXPORT SIGNALS; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80053932174     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.052     Document Type: Article

References (19)

1. Nicholson D.W., Thornberry N.A. Apoptosis. Life and death decisions. Science 2003, 299(5604):214-215.
2. Kastan M.B. A BID for the pathway. Nature 2005, 437(7062):1103.
3. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., El-Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002, 4(11):842-849.
4. Zinkel S.S., Hurov K.E., Ong C., Abtahi F.M., Gross A., Korsmeyer S.J. A role for proapoptotic BID in the DNA-damage response. Cell 2005, 122(4):579-591.
5. Kamer I., Sarig R., Zaltsman Y., et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005, 122(4):593-603.
6. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6(8):931-942.
7. Oberkovitz G., Regev L., Gross A. Nucleocytoplasmic shuttling of BID is involved in regulating its activities in the DNA-damage response. Cell Death Differ 2007, 14(9):1628-1634.
8. Song G., Chen G.G., Chau K.J., Miao J., Lai B.S. Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in human hepatoma cells. Apoptosis 2008, 13(5):693-701.
9. Song G., Chen G.G., Yun J.P., Lai P.B.S. Association of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinoma. Curr Cancer Drug Targets 2009, 9(7):871-880.
10. Song G., Chen G.G., Hu T.H., Lai P.B.S. Bid stands at the crossroad of stress-response pathways. Curr Cancer Drug Targets 2010, 10(6):584-592.
11. Cory S., Huang D.C., Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003, 22(53):8590-8607.
12. Janumyan Y.M., Sansam C.G., Chattopadhyay A., et al. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J 2003, 22(20):5459-5470.
13. Cheng N., Janumyan Y.M., Didion L., Van Hofwegen C., Yang E., Knudson C.M. Bcl-2 inhibition of T-cell proliferation is related to prolonged Tcell survival. Oncogene 2004, 23(21):3770-3780.
14. Bai L., Ni H.M., Chen X., Difrancesca D., Yin X.M. Deletion of bid impedes cell proliferation and hepatic carcinogenesis. Am J Pathol 2005, 166(5):1523-1532.
15. Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432(7015):316-323.
16. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116(2):205-219.
17. Kanai M., Hanashiro K., Kim S.H., et al. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol 2007, 9(10):1175-1183.
18. Mihara M., Erster S., Zaika A., et al. P53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003, 11(3):577-590.
19. Baptiste N., Prives C. p53 in the cytoplasm: a question of overkill?. Cell 2004, 116(4):487-489.